The Pause Technologies Completes Program in MedTech Innovation
In an exciting achievement, The Pause Technologies, a pioneering AI platform focused on menopause support, recently concluded its participation in the esteemed Mayo Clinic and Arizona State University MedTech Accelerator. This program is known for its selective nature, with only ten companies being chosen globally for the 2025 cohort. Notably, The Pause Technologies proudly stood out as the only female-founded organization in this year's group.
Empowering Women Through AI Technology
Founded with a vision to redefine menopause care, The Pause Technologies is dedicated to addressing a often overlooked segment of healthcare. With its proprietary platform, thePause™, users receive continuous real-time symptom support that integrates biometric feedback with clinical-grade insights. This innovative approach is revolutionizing how women experience and manage perimenopause and menopause.
A Unique Opportunity in Healthcare Innovation
The Mayo Clinic and ASU MedTech Accelerator is recognized as one of the top programs globally, specifically designed for early-stage medical technology companies. Participants benefit from direct access to a wealth of clinical, academic, and commercial expertise, fostering an environment where they can refine their healthcare solutions for real-world effectiveness.
Highlighting the Importance of Women’s Health
"The healthcare system often reacts rather than proactively addresses women’s midlife health needs," shared Susan Sly, the CEO and Founder of The Pause Technologies. She emphasized how recent discussions, like Oprah's special on menopause, have brought attention to the challenges faced by countless women. Susan further stated, "Our completion of this accelerator emphasizes our commitment to deliver intelligent, real-time support to women navigating menopause. Being the only female-founded company in this process highlights our mission to create solutions that women desperately need."
A Growing Market Demand
According to recent statistics, it is projected that over one billion women worldwide will experience menopause by 2030. This burgeoning demographic is creating a substantial demand for innovative health solutions tailored to their unique needs. ThePause™ is designed to step into this moment, offering adaptive and real-time support that empowers women to better understand and manage their health during significant hormonal phases.
Tackling Stigma and Misinformation
Dr. Mia Chorney, Chief Medical Officer and Co-founder of The Pause Technologies, echoed the urgency in addressing the stigma and misinformation surrounding menopause. She elaborated, "This program allowed us to enhance our clinical validation, examine our approach with noted experts, and expedite our strategy to deliver better health outcomes to women." Dr. Chorney's vision is clear: she seeks a world where menopause is regarded not as a burden, but as a natural phase of life supported by smart and empathetic technology.
Partnering for Greater Impact
The Pause Technologies is actively expanding partnerships with healthcare systems, wellness providers, and clinical researchers to broaden access and facilitate impactful change. This dynamic collaboration aims at increasing awareness and fostering a supportive environment for women facing menopause.
Discover More About The Pause Technologies
To discover more about The Pause Technologies and its groundbreaking AI platform for menopause support, interested individuals can visit www.thepause.ai.
Media Contact:
Diana Frerick
Director of Strategic Communications
The Pause Technologies
About The Pause Technologies
The Pause Technologies is at the forefront of advancing women’s health through its proprietary AI platform, which provides dedicated support during the perimenopause and menopause phases. Founded by accomplished AI entrepreneur Susan Sly, thePause™ aims to give women intelligent, personalized support to navigate hormonal changes with clarity. The company is based in Scottsdale, Arizona, and stands out as a women-founded, science-backed entity committed to driving change in women's healthcare.
Frequently Asked Questions
What is The Pause Technologies?
The Pause Technologies is an innovative AI platform focused on providing personalized support for women experiencing perimenopause and menopause.
What is the purpose of the Mayo Clinic and ASU MedTech Accelerator?
The accelerator aims to support early-stage medical technology companies by providing access to essential clinical, academic, and commercial expertise.
What makes thePause™ unique?
thePause™ delivers real-time symptom support, biometric feedback, and clinical-grade insights to transform the menopause experience for women.
Why is menopause often overlooked in healthcare?
Menopause has historically been surrounded by stigma and misinformation, leading to a lack of proactive care and attention within the healthcare system.
How is The Pause Technologies addressing the needs of women?
The Pause Technologies focuses on providing intelligent support and partnerships that enhance awareness and understanding of menopause, aiming to empower women's health.
